201943-63-7
201943-63-7 結(jié)構(gòu)式
基本信息
(ALPHAS)-ALPHA-氨基-ALPHA-[(1S,2S)-2-羧基環(huán)丙基]-9H-噸-9-丙酸
LY 341495
LY 341495
LY-341495
9H-Xanthene-9-propanoic acid, α-amino-α-[(1S,2S)-2-carboxycyclopropyl]-, (αS)-
(2S)-2-AMINO-2-[(1S,2S)-2-CARBOXYCYCLOPROP-1-YL]-3-(XANTH-9-YL) PROPANOIC ACID
(alphaS)-alpha-Amino-alpha-[(1S,2S)-2-carboxycyclopropyl]-9H-xanthene-9-propanoic acid
(1S,2S)-2-[(1S)-1-amino-1-carboxy-2-(9H-xanthen-9-yl)ethyl]cyclopropane-1-carboxylic acid
(alphaS)-alpha-Amino-alpha-[(1S,2S)-2-carboxycyclopropyl]-9H-xanthene-9-propanoic acid LY 341495
物理化學(xué)性質(zhì)
| 報(bào)價(jià)日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
| 2025/02/05 | HY-70059 | (2S)-2-氨基-2-[(1S,2S)-2-羧基環(huán)丙-1-基]-3-(噸-9-基)丙酸 LY341495 | 201943-63-7 | 1 mg | 500元 |
| 2025/02/05 | HY-70059 | (2S)-2-氨基-2-[(1S,2S)-2-羧基環(huán)丙-1-基]-3-(噸-9-基)丙酸 LY341495 | 201943-63-7 | 5mg | 1100元 |
| 2025/02/05 | HY-70059 | (2S)-2-氨基-2-[(1S,2S)-2-羧基環(huán)丙-1-基]-3-(噸-9-基)丙酸 LY341495 | 201943-63-7 | 10mM * 1mLin DMSO | 1210元 |
常見問題列表
|
mGluR1a 7.8 μM (IC 50 ) |
mGluR2 21 nM (IC 50 ) |
mGluR3 14 nM (IC 50 ) |
mGluR4 22 μM (IC 50 ) |
mGluR5a 8.2 μM (IC 50 ) |
mGluR7 990 nM (IC 50 ) |
mGluR8 170 nM (IC 50 ) |
LY341495 (0.3, 1, and 3 mg/kg, i.p.) displays a lower level of discrimination in rats. LY341495 (3.0 mg/kg) decreases Dvl-2, pGSK-3α/β and β-catenin protein levels but Dvl-1, Dvl-3 and GSK-3α/β are unaffected in both the PFC and STR. LY341495 has the generally the opposite effect following acute and chronic administration compared to mGlu2/3 agonist, LY379268. LY341495 (3 mg/kg, i.p., 2.5 h) -induced c-Fos expression is not altered in either KO brain. LY341495 is almost inactive in the central extended amygdala [central nucleus of the amygdala, lateral (CeL) and bed nucleus of the stria terminalis, laterodorsal (BSTLD)] in mGluR3-KO mice.